NCT03367156 2025-11-12
Dexamethasone in Controlling Dyspnea in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
10 trialsNCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02932332 2023-04-21
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02357134 2022-12-07
High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2 Unknown
NCT02063828 2021-03-05
RELAX
Wake Forest University Health Sciences
Phase NA Terminated
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01880528 2020-01-02
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
Mayo Clinic
Phase 2 Completed
NCT00934128 2016-03-02
High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00053846 2015-11-24
Buspirone in Reducing Shortness of Breath in Patients With Cancer
University of Rochester
Phase 2/3 Completed